TNDM
TNDM
NASDAQ · Health Care

Tandem Diabetes Care Inc

$24.82
+0.19 (+0.77%)
As of Mar 22, 10:09 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.03B
Net Income
-207,972,527
Gross Margin
53.8%
Profit Margin
-20.2%
Rev Growth
+8.2%
D/E Ratio
2.03
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 53.8% 53.8% 47.0% 47.0%
Operating Margin -18.4% -16.6% 15.5% 13.6%
Profit Margin -20.2% -19.2% 9.5% 12.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.03B 952.88M 506.05M 514.02M
Gross Profit 554.74M 512.74M 238.02M 241.76M
Operating Income -190,204,999 -158,225,805 78.47M 70.10M
Net Income -207,972,527 -173,006,076 48.01M 63.53M
Gross Margin 53.8% 53.8% 47.0% 47.0%
Operating Margin -18.4% -16.6% 15.5% 13.6%
Profit Margin -20.2% -19.2% 9.5% 12.4%
Rev Growth +8.2% +8.2% -3.6% +0.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 487.03M 487.03M 100.92M 108.12M
Total Equity 239.96M 239.96M 530.92M 572.70M
D/E Ratio 2.03 2.03 0.19 0.19
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -172,296,462 -151,290,913 116.78M 104.62M
Free Cash Flow 47.29M 46.73M